Published in Medical Device Business Week, November 11th, 2009
As a result, the noninvasive procedure has been contraindicated by the /U.S. Food and Drug Administration (FDA) (http://www.fda.gov/) for patients with cardiac...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.